Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Retinoblastoma × Platinum Compounds × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 6 Ovarian Neoplasms 5 Esophageal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Neoplasm Metastasis 2 Urinary Bladder Neoplasms 1 Squamous-Cell Lung Cancer 1 Retinoblastoma 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Resectable Non-small Cell Lung Cancer 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 Nonsquamous Non-small Cell Lung Cancer 1 NSCLC 1 Melanoma 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Carboplatin 19 Etoposide 17 Vincristine 13 Melphalan 10 Filgrastim 10 Granulocyte Colony-Stimulating Factor 9 Topotecan 8 Cyclophosphamide 8 Thiotepa 6 Mesna 4 Cryotherapy 4 Busulfan 4 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Ifosfamide 3 Drug Therapy 3 Doxorubicin 3 Watchful Waiting 2 Temozolomide 2 Magnetic Resonance Imaging 2 Eye Enucleation 2 Cisplatin 2 Brachytherapy 2 trioctyl phosphine oxide 1 sargramostim 1 racotumomab 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 omburtamab I-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡